Recombinant Human Cadherin-13 protein (rFc Tag)

Species

Human

Purity

>90 %, SDS-PAGE

Tag

rFc Tag

Activity

not tested

Cat no : Eg5964



Product Information

Purity >90 %, SDS-PAGE
Endotoxin <0.1 EU/μg protein, LAL method
Activity
Not tested
Expression HEK293-derived Human Cadherin-13 protein Ser139-Gly693 (Accession# P55290-1) with a rabbit IgG Fc tag at the C-terminus.
GeneID 1012
Accession P55290-1
PredictedSize 86.4 kDa
SDS-PAGE 90-115 kDa, reducing (R) conditions
Formulation Lyophilized from 0.22 μm filtered solution in PBS, pH 7.4. Normally 5% trehalose and 5% mannitol are added as protectants before lyophilization.
Reconstitution Briefly centrifuge the tube before opening. Reconstitute at 0.1-0.5 mg/mL in sterile water.
Storage Conditions
It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
  • Until expiry date, -20℃ to -80℃ as lyophilized proteins.
  • 3 months, -20℃ to -80℃ under sterile conditions after reconstitution.
Shipping The product is shipped at ambient temperature. Upon receipt, store it immediately at the recommended temperature.

Background

Cadherin-13 (CDH13, also known as H-cadherin or T-cadherin) is an atypical member of cadherin family, lacking transmembrane and cytosolic domains and anchored to the exterior surface of the plasma membrane via a GPI anchor. CDH13 is thought to affect cellular behavior largely through its signaling properties. It is highly expressed in heart, and in the CNS, CDH13 is expressed in cerebral cortex, medulla, hippocampus, amygdala, thalamus and substantia nigra. It is often down-regulated in cancerous cells.

References:

1. Philippova, Maria et al. Cellular signalling vol. 21,7 (2009): 1035-44. 2. Paredes, Joana et al. Clinical cancer research : an official journal of the American Association for Cancer Research vol. 11,16 (2005): 5869-77. 3. Xu, Yidong et al. Experimental and therapeutic medicine vol. 18,1 (2019): 841-847.

||
New chat

Able

正在加载,请稍候...